Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells
出版年份 2020 全文链接
标题
Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells
作者
关键词
-
出版物
Frontiers in Cell and Developmental Biology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-08-27
DOI
10.3389/fcell.2020.00865
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells
- (2020) Jingqiu Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells
- (2020) Jing-Quan Wang et al. Cancers
- A 2/1 Sunitinib Dosing Schedule Provides Superior Antitumor Effectiveness and Less Toxicity Than a 4/2 Schedule for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
- (2020) Huan Deng et al. Frontiers in Oncology
- Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor
- (2020) Chao-Yun Cai et al. BIOCHEMICAL PHARMACOLOGY
- The current role of BTK inhibitors in the treatment of Waldenstrom’s Macroglobulinemia
- (2020) Maria Gavriatopoulou et al. Expert Review of Anticancer Therapy
- Ibrutinib in Gynecological Malignancies and Breast Cancer: A Systematic Review
- (2020) Julian Matthias Metzler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aberrantly expressed Bruton’s tyrosine kinase preferentially drives metastatic and stem cell-like phenotypes in neuroblastoma cells
- (2020) Narpati Wesa Pikatan et al. CELLULAR ONCOLOGY
- Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells
- (2020) Weiguo Feng et al. Frontiers in Oncology
- Structural insight into substrate and inhibitor discrimination by human P-glycoprotein
- (2019) Amer Alam et al. SCIENCE
- Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study
- (2019) Ning Ji et al. Frontiers in Oncology
- Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells
- (2019) Qingbin Cui et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
- (2019) Chung-Pu Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo
- (2018) Guan-Nan Zhang et al. CANCER LETTERS
- Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters
- (2018) Ying-Fang Fan et al. CANCER LETTERS
- Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells
- (2018) Ning Ji et al. CANCER LETTERS
- The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors
- (2017) Hui Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Kinase Inhibitor Indole Derivatives as Anticancer Agents: A Patent Review
- (2017) Anuj K. Rathi et al. Recent Patents on Anti-Cancer Drug Discovery
- Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
- (2016) Zhaolin Chen et al. CANCER LETTERS
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Multidrug Resistance Proteins (MRPs) and Cancer Therapy
- (2015) Yun-Kai Zhang et al. AAPS Journal
- Discovery of novel Bruton’s tyrosine kinase (BTK) inhibitors bearing a pyrrolo[2,3-d]pyrimidine scaffold
- (2015) Xinge Zhao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis and evaluation of novel 5-phenylpyridin-2(1H)-one derivatives as potent reversible Bruton’s tyrosine kinase inhibitors
- (2015) Xinge Zhao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Pyrrolo[2,3-b]pyridine derivatives as potent Bruton’s tyrosine kinase inhibitors
- (2015) Xinge Zhao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Molecular mechanisms of drug resistance and its reversal in cancer
- (2015) Melis Kartal-Yandim et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study
- (2015) Rishil J. Kathawala et al. Oncotarget
- Btk inhibition suppresses agonist-induced human macrophage activation and inflammatory gene expression in RA synovial tissue explants
- (2014) Linda M Hartkamp et al. ANNALS OF THE RHEUMATIC DISEASES
- Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1
- (2014) Yi-Jun Wang et al. BIOCHEMICAL PHARMACOLOGY
- Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor
- (2014) W Guo et al. Cell Death & Disease
- Suppression of Glomerulonephritis in Lupus-Prone NZB × NZW Mice by RN486, a Selective Inhibitor of Bruton's Tyrosine Kinase
- (2013) Paola Mina-Osorio et al. ARTHRITIS AND RHEUMATISM
- Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
- (2012) Alfred H. Schinkel et al. ADVANCED DRUG DELIVERY REVIEWS
- The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2
- (2012) R. Sen et al. MOLECULAR CANCER THERAPEUTICS
- Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
- (2011) Amit K. Tiwari et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
- (2011) Chung-Pu Wu et al. MOLECULAR PHARMACEUTICS
- Multidrug resistance associated proteins in multidrug resistance
- (2011) Kamlesh Sodani et al. Chinese Journal of Cancer
- ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
- (2009) Paul D. W. Eckford et al. CHEMICAL REVIEWS
- Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
- (2009) Abdalla J. Mohamed et al. IMMUNOLOGICAL REVIEWS
- ABC Transporters, Drug Resistance, and Cancer Stem Cells
- (2009) Michael Dean JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Vandetanib (Zactima, ZD6474) Antagonizes ABCC1- and ABCG2-Mediated Multidrug Resistance by Inhibition of Their Transport Function
- (2009) Li-sheng Zheng et al. PLoS One
- Transport proteins of the ABC family and multidrug resistance of tumor cells
- (2008) A. A. Stavrovskaya et al. BIOCHEMISTRY-MOSCOW
- Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
- (2008) C.-l. Dai et al. CANCER RESEARCH
- Substrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay Design
- (2008) N. Giri et al. DRUG METABOLISM AND DISPOSITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now